Showing 4 posts of 4 posts found.

Trial of potential new COVID-19 treatment begins in UK

January 13, 2021
Research and Development COVID-19, Synairgen, Vaccine

A large-scale trial of a new COVID-19 treatment to prevent severe illness in coronavirus patients has begun in the UK. …


Synairgen drug doubles likelihood of recovery in hospitalised COVID-19 patients, early data show

July 20, 2020
Research and Development, Sales and Marketing COVID-19, Synairgen

Respiratory drug firm Synairgen has, like many, been hard at work on a treatment for patients with COVID-19; the company …


AstraZeneca forced to abandon Phase II trial

October 12, 2016
Research and Development AstraZeneca, Synairgen, asthma, cold, common cold

Synairgen, a respiratory drug discovery and development company, has developed a drug, AZD9412, alongside AstraZeneca to treat and prevent severe …

Astrazeneca image

AstraZeneca signs $240m asthma deal with UK biotech

June 12, 2014
Sales and Marketing AZ, AstraZeneca, COPD, SNG001, Synairgen

UK-based Synairgen has signed a global licence agreement with fellow British native AstraZeneca for its experimental lung drug SNG001. The …

Latest content